Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bruin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Acta Anatomica|January 1, 1993
Kinematics of the standardbred trotter measured at 6, 7, 8 and 9 m/s on a treadmill, before and after 5 months of prerace trainingP R van Weeren, A J van den Bogert, W Back, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Population PK-PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197S De Buck, W Hueber, A Vitaliti, et al.
The Veterinary Quarterly|January 1, 1992
Interference of maternal antibodies with the immune response of foals after vaccination against equine influenzaC van Maanen, G Bruin, E de Boer-Luijtze, et al.
Regional Anesthesia and Pain Medicine|October 17, 1998
Analgesic effect of interscalene block using low-dose bupivacaine for outpatient arthroscopic shoulder surgeryA Al-Kaisy, G McGuire, V W Chan, et al.
Equine Veterinary Journal|January 1, 1995
How the horse moves: 1. Significance of graphical representations of equine forelimb kinematicsW Back, H C Schamhardt, H H Savelberg, et al.
Equine Veterinary Journal|January 1, 1995
How the horse moves: 2. Significance of graphical representations of equine hind limb kinematicsW Back, H C Schamhardt, H H Savelberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2019
Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 yearsK Reich, A Blauvelt, A Armstrong, et al.
The British Journal of Dermatology|August 13, 2016
Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasisK Reich, A Blauvelt, A Armstrong, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Acta Anatomica|January 1, 1993
Kinematics of the standardbred trotter measured at 6, 7, 8 and 9 m/s on a treadmill, before and after 5 months of prerace trainingP R van Weeren, A J van den Bogert, W Back, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Population PK-PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197S De Buck, W Hueber, A Vitaliti, et al.
The Veterinary Quarterly|January 1, 1992
Interference of maternal antibodies with the immune response of foals after vaccination against equine influenzaC van Maanen, G Bruin, E de Boer-Luijtze, et al.
Regional Anesthesia and Pain Medicine|October 17, 1998
Analgesic effect of interscalene block using low-dose bupivacaine for outpatient arthroscopic shoulder surgeryA Al-Kaisy, G McGuire, V W Chan, et al.
Equine Veterinary Journal|January 1, 1995
How the horse moves: 1. Significance of graphical representations of equine forelimb kinematicsW Back, H C Schamhardt, H H Savelberg, et al.
Equine Veterinary Journal|January 1, 1995
How the horse moves: 2. Significance of graphical representations of equine hind limb kinematicsW Back, H C Schamhardt, H H Savelberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2019
Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 yearsK Reich, A Blauvelt, A Armstrong, et al.
The British Journal of Dermatology|August 13, 2016
Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasisK Reich, A Blauvelt, A Armstrong, et al.
Pageof 3